Source link : https://news.google.com/rss/articles/CBMiwwFBVV95cUxPal9QT3NyMGNZSklISGtsS0R4cFp1d25ZaW9kam1GMGhjOE5CcHZjbFZDTlVlMzZzN1hwekFMTHp4cjVuc0ZXbkdyNXYtYzUydTZ0QmhXWC0xRVRMUlkxeS1razI5VTVqcUFjUkRoR082cXN0c0hPWXRZbU1ZS1E3TFZja3V2bUZ1dERUd20tX1M4dzg3cWVpRFY2emJadkYtV01sVWNWZ1BUVHFCSUFyZENlU2Q5cTZvU3NHUWJGY0pnSFk?oc=5
Author :
Publish date : 2024-04-25 07:00:00
Copyright for syndicated content belongs to the linked Source.
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA – Biogen | Investor Relations
ADVERTISEMENT
ADVERTISEMENT
